Myomo Inc

$ 1.37

-11.04%

11 Jun - close price

  • Market Cap 54,488,000 USD
  • Current Price $ 1.37
  • High / Low $ 1.59 / 1.34
  • Stock P/E N/A
  • Book Value 0.23
  • EPS -0.36
  • Next Earning Report -
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.23 %
  • ROE -0.98 %
  • 52 Week High 2.89
  • 52 Week Low 0.60

About

Myomo, Inc., a portable medical robotics company, designs, develops and produces myoelectric braces for people with neuromuscular disorders in the United States. The company is headquartered in Boston, Massachusetts.

Analyst Target Price

$4.42

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-05-072026-03-092025-11-102025-08-112025-05-072025-03-102024-11-062024-08-062024-05-082024-03-072023-11-072023-08-09
Reported EPS -0.091-0.0852-0.09-0.12-0.08-0.01-0.03-0.03-0.1-0.07-0.06-0.04
Estimated EPS -0.086-0.084-0.11-0.1-0.1-0.0233-0.04-0.07-0.1-0.06-0.09-0.03
Surprise -0.005-0.00120.02-0.020.020.01330.010.040-0.010.03-0.01
Surprise Percentage -5.814%-1.4286%18.1818%-20%20%57.0815%25%57.1429%0%-16.6667%33.3333%-33.3333%

Next Quarterly Earnings

Reported Date
Fiscal Date Ending
Estimated EPS
Currency

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: MYO

...
Insider Buying: Thomas Kirk Acquires 40,002 Shares of Myomo Inc (MYO)

2026-06-09 23:11:24

Thomas Kirk, a Director at Myomo Inc, recently purchased 40,002 shares of the company, bringing his total holdings to 693,865 shares. This transaction is part of a trend over the past year where Kirk has acquired a significant number of shares without selling any, aligning with Myomo Inc's overall insider buying activity. Despite this insider confidence, Myomo Inc's stock, trading at $1.27 with a market cap of $50.618 million, is flagged as a "Possible Value Trap" by GuruFocus's GF Value of $3.11, suggesting caution.

MYOMO (MYO) CCO uses 6,529 shares to cover RSU tax liability

2026-06-09 21:11:24

MYOMO's Chief Commercial Officer, Micah Mitchell, reported a tax-withholding share disposition where 6,529 shares of common stock were delivered to cover income taxes from the vesting of restricted stock units on June 8, 2026, at $1.33 per share. Following this transaction, Mitchell directly holds 102,949 MYO shares. This event was a compensation-related share disposition rather than an open-market sale.

MYOMO (MYO) Chief Medical Officer disposes shares to cover RSU tax

2026-06-09 20:39:12

MYOMO's Chief Medical Officer, Harry Kovelman, disposed of 7,635 shares of common stock on June 8, 2026, at $1.33 per share. This transaction was solely to cover income taxes arising from restricted stock units (RSUs) that vested on June 5, 2026. Following this disposition, Kovelman directly holds 100,983 shares.

Director F. Kirk Thomas adds 40,002 Myomo (NYSE: MYO) shares in open-market buy

2026-06-09 20:11:24

Myomo director F. Kirk Thomas purchased 40,002 shares of common stock in an open-market transaction on June 5, 2026, at a weighted average price of $1.27 per share. This discretionary buy increased his direct holdings to 693,865 shares. The transaction, detailed in a Form 4 filing, signals a routine insider buy rather than a pre-scheduled event, as no 10b5-1 trading plan was referenced.

Myomo (NYSE: MYO) CFO uses 10,050 vested shares to cover tax bill

2026-06-09 20:11:24

Myomo's (NYSE: MYO) Chief Financial Officer, David A. Henry, had 10,050 shares of common stock withheld on June 8, 2026, to cover income taxes owed from restricted stock units that vested on June 5, 2026. This was a tax-withholding disposition, not an open-market sale. After this transaction, Henry directly holds 435,124 shares of MYO common stock.

...
Myomo CCO Mitchell Micah sells $77,688 in stock

2026-06-09 19:10:18

Myomo's Chief Commercial Officer, Mitchell Micah, sold 90,231 shares of the company's common stock for a total of $77,688 on May 14, 2026. This transaction occurred through open market sales at prices between $0.85 and $0.889 per share. Despite this insider sale, Myomo's stock has rallied significantly since May, and the company recently reported better-than-expected Q1 2026 financial results, though it is not expected to be profitable this year.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi